Bausch Health
BHC
#3482
Rank
NZ$5.39 B
Marketcap
$14.59
Share price
-2.23%
Change (1 day)
29.05%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$4.29

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$4.53. In 2022 the company made an earnings per share (EPS) of -$1.06 an increase over its 2021 EPS that were of -$4.53.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.29305.3%
2022-$1.06-76.64%
2021-$4.5368.45%
2020-$2.69-68.91%
2019-$8.65-57.11%
2018-$20.16-272.22%
2017$11.71-199.29%
2016-$11.79798.7%
2015-$1.31-128.31%
2014$4.63-204.62%
2013-$4.43602.7%
2012-$0.63-171.15%
2011$0.89-143.96%
2010-$2.02-206.57%
2009$1.89-11.2%
2008$2.132.46%
2007$2.08-7.58%
2006$2.25-14.29%
2005$2.6254%
2004$1.70-500%
2003-$0.43-141.67%
2002$1.02-4.76%
2001$1.07-175%
2000-$1.43-268%
1999$0.8514.94%
1998$0.7420.83%
1997$0.6153.83%
1996$0.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.70-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.46-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA